Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System

Completed · Not applicable

Conditions studied: Diabetes Mellitus

In brief

Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring (CGM) System

Key facts

Study ID

NCT02880267

Run by

DexCom, Inc.

People needed

304

Starts

2016-05-01

Expected to finish

2017-09-01

Last updated by the study team

2018-12-31

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 2 or older
• Diagnosis of Type 1 diabetes or Type 2 diabetes, on intensive insulin therapy
• Willing to participate in a clinic session involving venous sampling for evaluation of study end point

You may not qualify if…

• Use of acetaminophen
• Known allergy to medical-grade adhesives
• Pregnancy
• Hematocrit outside specification of the study-assigned blood glucose meter

Where it is running

• AMCR Institute — Escondido, California, United States
• Stanford — Palo Alto, California, United States
• Sansum — Santa Barbara, California, United States
• Diablo — Walnut Creek, California, United States
• Barbara Davis Center — Aurora, Colorado, United States
• Atlanta Diabetes — Atlanta, Georgia, United States
• Joslin Diabetes Center — Boston, Massachusetts, United States
• Oregon Health Science University — Portland, Oregon, United States
• Rainier — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.